Intrapleural injection of transforming growth factor-β antibody inhibits pleural fibrosis in empyema

Chest

Volumn 126, Issue 5, 2004, Pages 1636-1644

  Kunz, Craig R ^a   Jadus, Martin R ^b   Kukes, Gary D ^b   Kramer, Françoise ^c   Nguyen, Vu N ^a   Sasse, Scott A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Cytokines; Empyema; Fibrosis; Pleural

Indexed keywords

MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; EMPYEMA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PASTEURELLA MULTOCIDA; PLEURA FLUID; PLEURAL FIBROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RABBIT; TISSUE DISTRIBUTION;

EID: 8744289735     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.5.1636     Document Type: Article

References (40)

1. Light RW. Parapneumonic effusions and empyema. In: Light RW, ed. Pleural diseases. 4th ed. Philadelphia, PA: Lippincott, Williams and Wilkins, 2001; 151-181
2. Neiderman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-1426
3. Strange C, Sahn SA. The clinicians perspective on parapneumonic effusions and empyema. Chest 1993; 103:259-261
4. Sahn SA. State of the art: the pleura. Am Rev Respir Dis 1988; 138:184-235
5. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980; 69:507-511
6. Mitchell RN, Cotran RS. Repair: cell regeneration, fibrosis and wound healing. In: Kumar V, Cotran RS, Robbins SL, eds. Basic pathology. 6th ed. Philadelphia, PA: WB Saunders, 1992; 47-59
7. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 331:1286-1292
8. Kelley J. Transforming growth factor-β. In: Kelley J, ed. Cytokines of the lung. New York, NY: Marcel Dekker, 1993; 101-137
9. Wong TY, Phillips AO, Witowski J, et al. Glucose-mediated induction of TGF-β and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63:1404-1406
10. Corbel M, Germain N, Lanchou J, et al. The selective phosphodiesterase 4 inhibitor RP-73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-β release during acute lung injury in mice: the role of the balance between tumor necrosis factor-α and interleukin 10. Pharmacol 2002; 301:258-265
11. Khalil N, Bereznay O, Sporn M, et al. Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989; 170:727-737
12. 1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 2000; 47:277-290
13. 1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100:768-776
14. Branton MH, Kopp JB. TGF-β and fibrosis. Microbes Infect 1999; 1:1349-1365
15. Miyazono K. Positive and negative regulation of TGF-β signaling. J Cell Sci 2000; 113:1101-1109
16. Antony VB, Sahn SA, Mossman B, et al. Pleural cell biology in health and disease. Am Rev Respir Dis 1992; 145:1236-1239
17. Harvey W, Amlot PL. Collagen production by human mesothelial cells in vitro. J Pathol 1993; 139:337-347
18. Kinnula V, Linnala A, Viitala E, et al. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells. Am J Respir Cell Mol Biol 1998; 19:445-452
19. 2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000; 162:98-104
20. 2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 2001; 163:640-644
21. 2 produces effective pleurodesis in sheep with no systemic complications. Thorax 2000; 55:1058-1062
22. Wang Q, Wang Y, Hyde DM, et al. Reduction of bleomycin induced lung fibrosis by transforming growth factor soluble receptor in hamsters. Thorax 1999; 54:805-812
23. 1. Nature 1990; 346:371-374
24. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralizing antibody to transforming growth factor-β. Lancet 1992; 339:213-214
25. 1. J Surg Res 1996; 65:135-138
26. 1 correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 2003; 168:700-705
27. Sasse SA, Causing L, Mulligan M, et al. Serial pleural fluid analysis in a new experimental model of empyema. Chest 1996; 109:1043-1048
28. 1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989; 108:653-660
29. 1, and tissue factor and also cell growth and invasion activities. Cancer Res 2000; 60:6531-6536
30. Hung KY, Chen CT, Huang JW, et al. Dipyridamole inhibits TGF-β-indnced collagen gene expression in human peritoneal mesothelial cells. Kidney Int 2001; 60:1249-1257
31. Grande JP. Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med 1997; 214:27-40
32. Lee YCG, Lane KB. The many faces of transforming growth factor-β in pleural diseases. Curr Opin Pulm Med 2002; 8:173-179
33. 1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2003; 285:L527-L539
34. Rowland-Goldsmith MA, Maruyama H, Matsuda K, et al. Soluble type II transforming growth factor-β receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis. Mol Cancer Ther 2002; 1:161-167
35. Chung IM, Ueno H, Pak YK, et al. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-β type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications. Exp Mol Med 2002; 34:299-307
36. Wang Q, Hyde DM, Gotwals PJ, et al. Effects of delayed treatment with transforming growth factor-β soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters. Exp Lung Res 2002; 28:405-417
37. Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-B protects against scarring in experimental kidney disease. Nature 1992; 360:361-364
38. Flanders KC, Sullivan CD, Fujii M, et al. Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002; 160:1057-1068
39. 1 in mesenchymal stem cells: potential utility in molecular tissue engineering for osteochondral repair. Huazhong Univ Sci Tech Med Sci 2002; 22:112-115
40. 2, talc and bleomycin as pleurodesing agents in sheep. Respirology 2002; 7:209-216